Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,895.85 +18.80 (+0.24%) Bitcoin USD
64,294.95 +1,355.79 (+2.15%) CMC Crypto 200
1,384.14 +71.52 (+5.45%)
Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:32PM EDT. Market open.
| Previous close | 190.52 |
| Open | 190.72 |
| Bid | 192.30 x 100 |
| Ask | 192.99 x 100 |
| Day's range | 189.44 - 192.78 |
| 52-week range | 189.44 - 319.76 |
| Volume | |
| Avg. volume | 1,172,754 |
| Market cap | 28.005B |
| Beta (5Y monthly) | -0.01 |
| PE ratio (TTM) | 24.20 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
What's in Store for Biogen (BIIB) This Earnings Season?
Biogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of its multiple sclerosis drugs, while sales of Spinraza are likely to have been moderate.
- Zacks
Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Biogen (BIIB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
- Zacks
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.